Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proliferative bone lesions in rats given anticancer compounds.

C L Courtney1, S N Kim, K M Walsh

  • 1Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48105.

Toxicologic Pathology
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low frequency of MLLT10 risk SNPs in Korean meningiomas: an exploratory analysis highlighting population-specific differences.

The Malaysian journal of pathology·2026
Same author

Buccal mucosa micronuclei counts in relation to exposure to low dose-rate radiation from the Chornobyl nuclear accident and other medical and occupational radiation exposures.

Environmental health : a global access science source·2017
Same author

Dysfunctional information processing during an auditory event-related potential task in individuals with Internet gaming disorder.

Translational psychiatry·2016
Same author

Polysaccharides from Korean Citrus hallabong peels inhibit angiogenesis and breast cancer cell migration.

International journal of biological macromolecules·2016
Same author

Reoperation of Recurrent Gastric Cancer.

Cancer research and treatment·2015
Same author

A functional polymorphism in the CEBPE gene promoter influences acute lymphoblastic leukemia risk through interaction with the hematopoietic transcription factor Ikaros.

Leukemia·2015
Same journal

Comparison of Standard Clinical Pathology Parameter Values in Fasted and Fed Rats and Non-human Primates.

Toxicologic pathology·2026
Same journal

Time-Dependent Autolysis in Ex Vivo-Maintained Rat Tissue in Saline: A Descriptive Study and Practical Guidance for Histopathologic Assessment.

Toxicologic pathology·2026
Same journal

New Approach Methodologies (NAMs) for Carcinogenicity Evaluation.

Toxicologic pathology·2026
Same journal

2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.

Toxicologic pathology·2026
Same journal

Toxicologic Pathology Forum*: Opportunities and Challenges in the Use of Artificial Intelligence in Nonclinical Toxicologic Histopathology Evaluations.

Toxicologic pathology·2026
Same journal

New Modalities and Carcinogenicity Assessment.

Toxicologic pathology·2026
See all related articles

Anticancer drugs can cause bone marrow injury, leading to new bone formation and myelostromal proliferation in rats. This study observed these proliferative endosteal lesions after administering trimetrexate glucuronate, pentostatin, and CI-980.

Area of Science:

  • Oncology
  • Toxicology
  • Bone Biology

Background:

  • Anticancer therapies can have diverse toxicological effects.
  • Understanding drug-induced bone marrow changes is crucial for patient safety.
  • Endosteal bone formation is a complex biological process.

Purpose of the Study:

  • To investigate the bone marrow response to different anticancer compounds.
  • To characterize the nature and timing of proliferative endosteal lesions induced by chemotherapy.
  • To explore the potential mechanisms linking drug-induced injury to bone formation.

Main Methods:

  • Administration of three distinct anticancer compounds (trimetrexate glucuronate, pentostatin, CI-980) to Wistar rats.
  • Histopathological examination of femur and sternebra at various time points post-administration.

Related Experiment Videos

  • Evaluation of endosteal lesions, including woven bone formation and myelostromal proliferation.

    • Main Results:

    • Trimetrexate glucuronate induced woven bone and myelostromal proliferation.
    • Pentostatin caused transient bone lesions on Day 4.
    • CI-980 led to marrow necrosis, new bone formation, and myelostromal proliferation.

    Conclusions:

    • Chemically distinct anticancer agents can induce local bone marrow injury.
    • Drug-induced inflammatory mediators may stimulate bone formation and myelostromal proliferation.
    • These findings highlight potential off-target effects of chemotherapy on bone.